Search

everythinglearnresearchcommunity

for

Search:↓

Skin problems in COVID-19 patients are rare and may be due to the body's complex immune response or blood clotting issues.

Early diagnosis and tailored treatments are crucial for managing ichthyosis syndromes with hair abnormalities.

Corin helps control salt and sweat release in sweat glands.

The ACE1 gene variant doesn't affect long-COVID symptoms.

Lack of cystatin M/E causes thin hair and dry skin.

Age affects how certain proteins involved in COVID-19 infection are expressed in mice, but sex hormones and heart injury do not.

Proxalutamide improved blood markers related to inflammation, immune response, and clotting in COVID-19 patients, potentially reducing hospitalizations.

After severe COVID-19, 71% of patients experienced excessive hair shedding and thinning within 3 months due to factors like low oxygen levels, medication, stress, and autoimmune disease.

COVID-19 may worsen with androgens; anti-androgen drugs could help.

Sex hormones may affect COVID-19 severity, with estrogen possibly reducing risk and testosterone potentially increasing it.

Certain genetic differences may affect how likely someone is to get COVID-19 and how severe it might be.

Men's sensitivity to male hormones might affect how severe COVID-19 gets for them.

Anti-androgen therapy may boost immunity but increases injection site pain in vaccinated patients.

AGA linked to worse COVID-19 outcomes in men.

Anti-androgens, like finasteride, dutasteride, and spironolactone, may lessen the severity of COVID-19 in men, leading to fewer ICU admissions.

A certain genetic variant in the androgen receptor may predict the severity of COVID-19 in men.

Trapa bispinosa Roxb. extract may help reduce prostate size and cell growth in BPH.

Blocking the virus's entry into cells by targeting certain pathways could lead to early COVID-19 treatments.

New treatments targeting androgen receptors show promise for drug-resistant prostate cancer.

Long COVID-19 patients with skin pain might have a nerve condition that responds to a medication called gabapentin.

Use telemedicine and strict hygiene for safe hair and scalp treatments during COVID-19.

Having a lot of gray hair and hair loss are linked to more severe COVID-19.

Men, particularly those with hair loss, are more likely to get the virus, and those with prostate cancer may have milder symptoms. Testosterone's role in the disease is unclear, and the virus doesn't seem to harm male fertility. Women with PCOS might be at higher risk. More research is needed.

5-alpha reductase inhibitors might worsen lung recovery in COVID-19 patients, suggesting a pause in their use.

COVID-19 and hypopituitarism (reduced pituitary gland function) are linked, with the latter's related health issues potentially worsening COVID-19 outcomes, and COVID-19 possibly increasing risk for pituitary complications.

Proxalutamide significantly lowered hospital admissions for male COVID-19 patients compared to a placebo.

The trial will test if proxalutamide is safe and effective in reducing death in severe COVID-19 patients.

The conclusion is that individual differences in COVID-19 severity are influenced by factors like age, sex, race, and genetics, which are important for personalized medicine.

5-alpha-reductase inhibitors may reduce COVID-19 symptoms in bald males.

The conclusion suggests that prostate cancer should be classified by castration status and that new therapies targeting androgen receptor signaling show promise.